AIDS Research and Human Retroviruses

Titel Veröffentlichungsdatum Sprache Zitate
Safety and Tolerability of Co-formulated Tenofovir/Emtricitabine/Elvitegravir/Cobicistat (“Quad”) for Non-occupational Post-exposure Prophylaxis2014/10/01English
Humic Acids (HA) Strongly Potentiate Anti-HIV Effects of AZT, Griffithsin, and Cyanovirin2014/10/01English
Understanding of Viral Load among Participants Receiving Financial Incentives for ART Adherence: Findings from a Qualitative Substudy of HPTN 0652014/10/01English
Performance of the Wisebag™ for Monitoring Daily Rectal Gel Application in Two Urban Cities in the United States2014/10/01English
The Research Registry: A Valuable Strategy for Longitudinal Success in HIV Prevention Research Recruitment2014/10/01English
The Need for Multi-product Technologies for Women Participating in Vaginal Microbicide Trials2014/10/01English
Challenges with Participant Reimbursement: Experiences from CAPRISA 008 - A Post-trial Access Study2014/10/01English
Impact of DSMB Outcomes on Participation in HIV Prevention Trials: The VOICE Study Experience in Kampala, Uganda2014/10/01English
Are Nigerian Healthcare Providers (HCP) Prepared for Men Who Have Sex with Men (MSM): Lessons from the Mystery Client Survey in Nigeria?2014/10/01English
Serial in vivo Passage of CXCR4-tropic Simian/Human Immunodeficiency Chimeric Virus (SHIV89.6P) in Papio Anubis; A Preclinical Disease Model2014/10/01English
Acute SIV Infection Rapidly Depletes CD4+ pDCs, but Induces Gut-Homing pDCs from Bone Marrow2014/10/01English
Does Culture Affect Counselling in HIV Prevention Research?2014/10/01English
VLP-expressing DNA/MVA Vaccines: The Effect of Schedule and Regimen on Antibody Magnitude and Avidity2014/10/01English
Transmitter Founder Multi-envelope DNA Vaccine Induces Potent Cross-clade Cellular and Humoral Responses in Rabbits and Non-human Primates2014/10/01English
Mini CD4-heparan Sulfate Mimetic Conjugates Display Sub Nanomolar Anti-HIV-1 Activity and Protect Macaques against a SHIV162P3 Vaginal Route Challenge2014/10/01English
V2/C2 Region of HIV-1 Clade C Primary Envelopes Confer Altered Neutralization Susceptibilities to IgG1b12 and PG9 Monoclonal Antibodies2014/10/01English
Alternative Tenofovir Gel Formulations: Safety and Drug Absorption in the Macaque Model2014/10/01English
Geographic Utilization of Gift Cards Used for Financial Incentives to Encourage Viral Suppression: Findings from HPTN 0652014/10/01English
Shielding of the HIV-1 Envelope Membrane Proximal External Region (MPER) from Antibody2014/10/01English
Maximizing Participant Retention in a Phase2 B HIV Prevention Trial in Kampala, Uganda: The MTN-003 (VOICE Study)2014/10/01English
Assessing the Acceptability of the PrePex™ Device for Voluntary Medical Male Circumcision in South Africa2014/10/01English
Optimization of a Clade A Env Outer Domain for Enhanced Binding to Germlines of Diverse VRC01 Class Antibodies2014/10/01English
The Expression Analysis of Hexokinase 1 Gene in the Pumwani Commercial Sex Worker Cohort, Nairobi, Kenya2014/10/01English
Deletion of Immunomodulatory A44L, A46R and C12L Viral Genes from Modified Vaccinia Ankara (MVA) Genome: Effect on its Immunogenicity2014/10/01English
Partial Protection by Vaccination Does Not Prevent Chronic Neuro-inflammation in an SIV Model2014/10/01English
Getting Multi-purpose Prevention to Women Now! A Business Case for Female Condoms2014/10/01English
Abstract Author Index by abstract number2014/10/01English
HIV-specific Antibody in Rectal Secretions Following Late Boosts in RV144 Participants (RV305)2014/10/01English
Choosing Appropriate Interventions and Defining Locally Achievable Standard of Care for HIV Prevention Trials in Africa: A Multidisciplinary Approach2014/10/01English
Antibody-based PrEP and Cross-reactivity2014/10/01English